Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), a developer of dialysis-like therapies to address cardiovascular disease and cancer, today released a note authored by inventor and ...
IP-2026 introduces 3,340 monographs with blood component, excipient standards to boost patient safety: Shardul Nautiyal, Mumbai Tuesday, January 6, 2026, 08:00 Hrs [IST] In a sign ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback